Physical Activity, Overall Survival Not Linked in Metastatic Colorectal Cancer
Nine or more MET hours per week tied to lower risk for grade ≥3 treatment-related adverse events.
Colorectal Cancer
Cardiovascular Disease-related Chronic Conditions Among Veterans Affairs nonmetastatic Colorectal Cancer Survivors: A Matched Case–control Analysis
[Cancer Management and Research] This retrospective study investigated the likelihood of CVD-related chronic conditions being diagnosed in survivors of nonmetastatic CRC and of effective management of these conditions over 12 months following CRC diagnosis.
Patients, Caregivers Share High Level of Agreement in Assessments of Colorectal Cancer Care
Survey results show level of concordance between patients with CRC and their caregivers when rating care quality. The survey also measured whether clinical or demographic factors influenced the agreement between patient-caregiver pairs.
Biosimilars Mvasi, Kanjinti Now Available in the US
Biosimilars Mvasi and Kanjinti are now available in the United States.
Can Vitamin D Supplementation Improve Progression-Free, Relapse-Free Survival in Gastrointestinal Cancers?
In 2 randomized clinical trials, investigators sought to determine if use of vitamin D supplements improved PFS and RFS for patients with digestive tract cancers.
Incidence of Early-Onset Colon and Rectal Cancers Highest in Southern US States but Rising Fastest in Western US States
The incidence of early onset colorectal cancer per 100,000 people increased from 6.7 during 1995-1996 to 11.5 during 2014-2015 for residents of the state of WA.
Comparing Long-Course Chemoradiation With Short-Course Radiation Therapy in Rectal Cancer
Early results from the Polish II study showed a significant improvement in OS for preoperative short-course RT/chemotherapy compared with long-term chemo-RT.
First States to Expand Medicaid Had Largest Bump in Cancer Screening
States expanding Medicaid later had screening rates more comparable to nonexpansion states.
Yogurt Consumption Linked to Reduced CRC Adenoma Risk in Men
Men with two or more servings of yogurt per week have reduced risk for conventional adenoma.
Frontline FOLFOXIRI Plus Bevacizumab Improved PFS in mCRC: Phase 3 Trial Results
The VISNU-1 trial is “the first study performed in a population selected by baseline [circulating tumor cell] count,” according to lead study author Javier Sastre, MD, PhD.
Next post in ASCO 2019 Annual Meeting
